asco: promising results for trastuzumab deruxtecan for her2 gastric cancer
Published 3 years ago • 226 plays • Length 5:25Download video MP4
Download video MP3
Similar videos
-
6:45
trastuzumab deruxtecan for patients w/ her2-positive advanced gastric or ge junction adenocarcinoma
-
4:41
destiny-gastric03: trastuzumab deruxtecan in her2-overexpressing gastric cancer
-
1:58
destiny-gastric02: t-dxd as a second-line treatment for her2-positive gastric cancer
-
6:17
asco: current data and outlook for targeting her2 in gastrointestinal cancer
-
4:39
latest news in gastric cancer from asco gi
-
7:00
asco 2009: standard treatment plus trastuzumab for her2 gastric cancer
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
5:59
trastuzumab deruxtecan for the treatment of her2 breast cancer
-
14:55
asco: perioperative targeting of her2 for gastroesophageal cancer
-
34:31
chair's take: her2-targeted and other agents for gastric cancer
-
13:32
asco: new data and implications for immunotherapy in gastric cancer
-
1:43
gasther2: trastuzumab for advanced gastric cancer
-
3:50
fda approves fam-trastuzumab deruxtecan-nxki for her2 positive gastric adenocarcinomas
-
8:01
innovation: chemotherapy with trastuzumab and pertuzumab in her2 gastric cancer
-
1:07:30
personalizing gastric cancer care with her2-targeted and other novel therapies
-
3:12
advances in her2-targeted therapies for gastric cancer
-
6:38
potential new options for patients with her2 gastric cancer
-
2:40
destiny-gastric02: 2l t-dxd in her2 gastric cancers
-
8:17
metastatic gastric cancer: indications and impact of targeting the her2 pathway?